Effects of fullerene C60 on liver tissue in liver ischemia reperfusion injury in rats undergoing sevoflurane anesthesia

References

• Konishi T, Lentsch AB. Hepatic ischemia/reperfusion: mechanisms of tissue injury, repair, and regeneration. Gene Expr. 2017;17(4):277–9. doi: 10.3727/105221617X15042750874156
   PubMedGoogle Scholar
• Kalogeris T, Baines CP, Krenz M, et al. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–317.
   PubMed Web of Science ®Google Scholar
• Liao X, Zhou S, Zong J, et al. Sevoflurane exerts protective effects on liver ischemia/reperfusion injury by regulating NFKB3 expression via miR-9-5p. Exp Ther Med. 2019;17:2632–2640. doi: 10.3892/etm.2019.7272
   PubMed Web of Science ®Google Scholar
• Beck-Schimmer, Roth Z’graggen B, Booy C, et al. Sevoflurane protects hepatocytes from ischemic injury by reducing reactive oxygen species signaling of hepatic stellate cells: translational findings based on clinical trial. Anesth Analg. 2018;127(4):1058–1065
   PubMed Web of Science ®Google Scholar
• Nikalje AP. Nanotechnology and its applications in Medicine. Med Chem. 2015;5(2):081–9. doi: 10.4172/2161-0444.1000247
   Google Scholar
• Amani H, Habibey R, Hajmiresmail SJ, et al. Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. J Mater Chem B. 2017;5(48):9452–9476. doi: 10.1039/C7TB01689A
   PubMed Web of Science ®Google Scholar
• Du Y, Huo Y, Yang Q, et al. Ultrasmall iron-gallic acid coordination polymer nanodots with antioxidative neuroprotection for PET/MR imaging-guided ischemia stroke therapy. Exploration. 2023;3(1):20220041. doi: https://doi.org/10.1002/EXP.20220041
   Google Scholar
• Guan Y, Yao W, Yi K, et al. Nanotheranostics for the management of hepatic ischemia-reperfusion injury. Small. 2021;17(23):2007727. doi: https://doi.org/10.1002/smll.202007727
   Web of Science ®Google Scholar
• Moussa F. (60) Fullerene and derivates for biomedical applications. In: Nanobiomaterials. Cambridge, UK: Woodhead Publishing; 2018. p. 113–136.
   Google Scholar
• Chaudhuri P, Paraskar A, Soni S, et al. Fullerenol−cytotoxic conjugates for cancer chemotherapy. ACS Nano. 2009;3(9):2505–2514. doi: 10.1021/nn900318y
   PubMed Web of Science ®Google Scholar
• Halenova TI, Vareniuk IM, Roslova NM, et al. Hepatoprotective effect of orally applied water-soluble pristine C60 fullerene against CCl4-induced acute liver injury in rats. RSC Adv. 2016;6(102):100046–100055
   Web of Science ®Google Scholar
• Injac R, Radic N, Janković B, et al. Bioapplication and activity of fullerenol C60(OH)24. Afr J Biotechnol. 2008;7:4940–4050.
   Google Scholar
• Abdel-Wahhab MA, Nada SA, Arbid MS. Ochratoxicosis: prevention of developmental toxicity by L-methionine in rats m. J Appl Toxicol. 1999;19(1):7–12. doi: 10.1002/(SICI)1099-1263(199901/02)19:1<7:AID-JAT529>3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Van Ye TM, Roza AM, Pieper GM, et al. Inhibition of intestinal lipid peroxidation does not minimize morphologic damage. J Surg Res. 1993;55(5):553–558
   PubMed Web of Science ®Google Scholar
• Aebi H. Isolation, purification, characterization, and assay of antioxygenic enzymes [13] catalase in vitro. Methods Enzymol. 1984;105:121–126.
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases.The first enzymatic step in mercapturic acid formation. Journal Of Biological Chemistry. 1974;249(22):7130–7139. doi: 10.1016/S0021-9258(19)42083-8
   PubMed Web of Science ®Google Scholar
• Pagano D, Oliva E, Khouzam S, et al. The addition of simvastatin administration to cold storage solution of explanted whole liver grafts for facing ischemia/reperfusion injury in an area with a low rate of deceased donation: a monocentric randomized controlled double-blinded phase 2 study. BMC Surg. 2018;18(1):122
   PubMedGoogle Scholar
• Li H, Sun JJ, Chen GY, et al. Carnosic acid nanoparticles suppress liver ischemia/reperfusion injury by inhibition of ROS, caspases and NF-kappaB signaling pathway in mice. Biomed Pharmacother. 2016;82:237–246. doi: 10.1016/j.biopha.2016.04.064
   PubMed Web of Science ®Google Scholar
• Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury—a fresh look. Exp Mol Pathol. 2003;74(2):86–93. doi: 10.1016/S0014-4800(03)00008-X
   PubMed Web of Science ®Google Scholar
• Yabe Y, Kobayashi N, Nishihashi T, et al. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther. 2001;298(3):894–899.
   PubMed Web of Science ®Google Scholar
• Bardallo RG, Panisello-Roselló A, Sanchez-Nuno S, et al. Nrf2 and oxidative stress in liver ischemia/reperfusion injury. The FEBS Journal. 2021;289(18):5463–5479. doi: 10.1111/febs.16336
   Web of Science ®Google Scholar
• Cannistrà M, Ruggiero M, Zullo A, et al. Hepatic ischemia reperfusion injury: a systematic review of literature and the role of current drugs and biomarkers. Int J Surg. 2016;33:S57–70. doi: 10.1016/j.ijsu.2016.05.050
   PubMed Web of Science ®Google Scholar
• Alexandrova A, Petrov L, Georgieva A, et al. Effect of MG132 on proteasome activity and prooxidant/antioxidant status of rat liver subjected to ischemia/reperfusion injury. Hepatol Res. 2008;38(4):393–401
   PubMed Web of Science ®Google Scholar
• Cai L, Li Y, Zhang Q, et al. Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3beta/Nrf2-dependent antioxidant response and mitochondrial permeability transition. Eur J Pharmacol. 2017;806:32–42. doi: 10.1016/j.ejphar.2017.04.011
   PubMed Web of Science ®Google Scholar
• Su S, Luo D, Liu X, et al. miR-494 up-regulates the PI3K/Akt pathway via targetting PTEN and attenuates hepatic ischemia/reperfusion injury in a rat model. Biosci Rep. 2017;37(5):BSR20170798
   PubMedGoogle Scholar
• Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury—a fresh look. Exp Mol Pathol. 2003;74(2):86–93. doi: 10.1016/S0014-4800(03)00008-X
   PubMed Web of Science ®Google Scholar
• Srdjenovic B, Milic-Torres V, Grujic N, et al. Antioxidant properties of fullerenol C60(OH)24 in rat kidneys, testes, and lungs treated with doxorubicin. Toxicol Mech Methods. 2010;20(6):298–305
   PubMed Web of Science ®Google Scholar
• Kartal H, Küçük A, Kılıçarslan A, et al. The effect of fullerenol C60 on skeletal muscle after lower limb ischemia reperfusion injury in streptozotocin-induced diabetic rats. J Surg Med. 2020;4(6):451–455
   Google Scholar
• Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res. 2009;43(4):348–364. doi: 10.1080/10715760902751902
   PubMed Web of Science ®Google Scholar
• Kuznietsova H, Dziubenko N, Herheliuk T, et al. Water-soluble pristine C60 fullerene inhibits liver alterations associated with hepatocellular carcinoma in rat. Pharmaceutics. 2020;12(9):794. doi: 10.3390/pharmaceutics12090794
   PubMed Web of Science ®Google Scholar
• Elshater AA, Haridy MAM, Salman MMA, et al. Fullerene C60 nanoparticles ameliorated cyclophosphamide-induced acute hepatotoxicity in rats. Biomed Pharmacother. 2018;97:53–59. doi: 10.1016/j.biopha.2017.10.134
   PubMed Web of Science ®Google Scholar
• Injac R, Perse M, Obermajer N, et al. Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials. 2008;29(24–25):3451–3460
   PubMed Web of Science ®Google Scholar
• Injac R, Perse M, Cerne M, et al. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials. 2009 Feb;30(6):1184–1196. Epub 2008 Dec 1. PMID: 19046599. doi: 10.1016/j.biomaterials.2008.10.060
   PubMed Web of Science ®Google Scholar
• Liu H, Yuan Y, Rao D. Sevoflurane alleviates liver ischemia reperfusion injury through inactivation of the TRAF6/NF-κB signaling pathway. Trop J Pharm Res. 2021;20(10):2043–2048. doi: 10.4314/tjpr.v20i10.5
   Web of Science ®Google Scholar
• Injac R. Potential Medical use of fullerenols after two decades of oncology Research. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231201515. PMID: 37724005; PMCID: PMC10510368. doi: 10.1177/15330338231201515
   Web of Science ®Google Scholar